Individualised immunotherapy medicine
Tender ID: 550987
Tender Details
Organisation:
Tender #:
AHCM 312 02 IMM(PQQ)
Status:
Closed
Publish Date:
29 February 2024
Closing Date:
15 March 2024
Tender Description
Austin Health is pleased to invite you to respond to this PQQ.
Austin Health is seeking a supplier who can provide:
- Manufacture and supply of Autologous anti-CD19 CAR-T cell for therapy in relapsed CD19+ Diffuse large B cell lymphoma, primary mediastinal B-cell lymphoma, follicular lymphoma and mantle cell lymphoma according to MSAC guidelines.
The aim of the questionnaire is to:
- Identify the number of suppliers in the Australian market
- Identify suppliers who can meet Austin Health requirements
Following the evaluation of the PQQ submissions, suitable suppliers may be shortlisted and invited to respond to a Request for Quote (RFQ).